However, in contrast to our data identifying NNAT as a putative tumor suppressor in MLS, it was recently shown that high NNAT expression correlates with decreased survival of patients with glioblastoma [98], and that silencing of NNAT through miR-708 promotes cell migration and metastasis formation in breast cancer [99]. The gene discussed is NNAT; the disease is glioblastoma.